There are 2867 resources available
1664MO - Tumor-naïve methylomes and fragmentomes during pembrolizumab (P) in metastatic cancer patients
Presenter: Eric Zhao
Session: Mini Oral session: Basic science & translational research
Resources:
Abstract
Slides
Webcast
513MO - Risk and mortality of testicular cancer in patients with psychiatric or neurodevelopmental disorders
Presenter: Anna Jansson
Session: Mini Oral session 1: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Invited Discussant 1310MO, 512MO and 513MO
Presenter: Aly-Khan Lalani
Session: Mini Oral session 1: GU tumours, non-prostate
Resources:
Slides
Webcast
69MO - 5-Hydroxymethycytosine analysis reveals stable epigenetic changes in tumor tissue that enable cfDNA cancer predictions
Presenter: Felix Feng
Session: Mini Oral session: Basic science & translational research
Resources:
Abstract
Slides
Webcast
Invited Discussant 905MO, 1664MO and 69MO
Presenter: Sarah-Jane Dawson
Session: Mini Oral session: Basic science & translational research
Resources:
Slides
Webcast
Presentation by Expert
Presenter: Nancy Lin
Session: CNS metastases in metastatic breast cancer
Resources:
Slides
Webcast
Presentation by Expert
Presenter: Martin van den Bent
Session: Management of different glioma subtypes: Should all lower-grade gliomas be treated equally?
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Martine Piccart
Session: CNS metastases in metastatic breast cancer
Resources:
Slides
Webcast
Fatigue, cognitive dysfunction and emotional distress
Presenter: Karen Steindorf
Session: Minimizing some of the most distressing cancer and cancer treatment related symptoms
Resources:
Slides
Webcast
525MO - Updated efficacy and safety of lenvatinib (LEN) + pembrolizumab (pembro) vs treatment of physician’s choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Study 309/KEYNOTE-775
Presenter: Vicky Makker
Session: Mini Oral session 2: Gynaecological cancers
Resources:
Abstract
Slides
Webcast